One hundred and thirty-eight isolates of Klebsiella pneumoniae showing resistance to ceftazidime were isolated from different wards of the Hospital de Santa Maria, Lisbon. The genomic DNA of the isolates was analysed by pulsed-field gel electrophoresis (PFGE) and two patterns were predominant. In all isolates the presence of a single large plasmid of about 50 kb suggested that propagation of the outbreak prominently involved plasmid spread. The deduced amino acid sequence indicated the presence of a TEM-10 -lactamase. This extended-spectrum -lactamase was present among K. pneumoniae isolates, was widely disseminated in different wards and remained persistent as a result of an outbreak involving the dissemination of both the multi-resistance plasmids harbouring the bla gene and the isolates themselves.
Introduction
-Lactamases are the most common cause of bacterial resistance to -lactam antimicrobial agents. 1 Klebsiella pneumoniae, an important cause of nosocomial infections, is among those organisms that produce extended-spectrum -lactamases (ESBLs). Many ESBLs have already been identified world-wide in the genus Klebsiella, and it is difficult to define which enzyme types are most important. TEM-3 appears to be the most common type in France 2 whereas TEM-10, TEM-12 and TEM-26 predominate in the USA. 3, 4 In Portugal very little is known about the presence of ESBLs in the genus Klebsiella. The present work was undertaken to characterize the resistance to ceftazidime found in K. pneumoniae isolated in a Lisbon hospital over a period of 6 years, to assess the extent to which these resistant isolates were significant in the various wards examined, and to detect the possible existence of a new ESBL.
Materials and methods

Bacterial isolates
A survey of K. pneumoniae resistant to ceftazidime from the Hospital de Santa Maria in Lisbon was carried out between April 1995 and March 1996. A total of 130 isolates was isolated from the intensive care unit, as well as from the internal medicine, surgery and paediatric wards. These isolates were from urine (72), blood cultures (25), respiratory tract (15) and other clinical specimens (18) including wounds, drainage fluids, catheter and faeces. In addition, eight isolates from sporadic cases (collected between 1991 and 1993 and during 1997) were also obtained from the neonatal intensive care unit (NICU) of the same hospital (three from respiratory tract, two from blood cultures, one from urine and two from environmental analysis).
All isolates were identified with the API 20E System (API System, bioMérieux, Lisbon, Portugal). Antibiotic susceptibility testing and genotypic analysis were performed on 5 was used as the recipient for mating experiments. E. coli C600 (pCFF14) expressing CAZ-1/TEM-5, E. coli C600 (pCFF74) expressing CAZ-6/TEM-24, E. coli C600 (pCFF84) expressing CAZ-7/TEM-16 (all provided by Dr C. Chanal), E. coli J53 (pMG223) expressing TEM-10 and E. coli J53 (pMG225) expressing TEM-26 (both provided by Dr G. Jacoby) were used as references for -lactamases studies. E. coli TG1 and E. coli TOP 10FЈ (Alfagene, Lisbon, Portugal) were used in the transformation reactions.
Survey of
Antibiotic susceptibility testing
Susceptibility to antimicrobial agents was determined by the standard disc diffusion method on Mueller-Hinton agar as described by the NCCLS. 6 The following agents were tested: amoxycillin, amoxycillin plus clavulanic acid, cefoxitin, cefuroxime, ceftazidime, cefotaxime, aztreonam, imipenem, gentamicin, amikacin, netilmicin, norfloxacin, pefloxacin and nalidixic acid. The double-disc synergy test between clavulanic acid and extended-spectrum cephalosporins was used to detect production of ESBLs according to the method described by Ben Redjeb et al. 7 The MICs of ceftazidime, aztreonam, cefepime, cefotaxime, cefuroxime and ceftazidime plus clavulanic acid were determined using Etest strips (AB Biodisk, Solna, Sweden) on MuellerHinton agar.
Genotypic analysis by PFGE
Chromosomal DNA from each isolate was prepared and digested with XbaI (Biolabs) as described by Maslow et al. 8 The restriction fragments generated were separated on a 1% agarose gel (SeaKem; B. Brown, Lisbon, Portugal) in 0.5ϫ TBE buffer, pH 8.0. A Bio-Rad CHEF DRII apparatus (Paci, Lisbon, Portugal) was used at 200 V and 15°C for 22 h, with pulse times of 1-40 s, ramped linearly. A ladder of bacteriophage lambda concatemers (IZASA, Lisbon, Portugal) was used to determine the size of XbaI restriction fragments. Gels were interpreted as recommended by Tenover et al. 9 
Conjugal transfer of ceftazidime resistance
Conjugation was performed using the plate-mating method. 10 Transconjugants were selected on agar containing ceftazidime and nalidixic acid at concentrations of 30 and 50 mg/L, respectively.
Isoelectric focusing
Crude preparations of -lactamases from K. pneumoniae and from their transconjugants were obtained by sonicating the cells in phosphate buffer, pH 7.0. IEF was performed by the method of Matthew et al. 11 using an LKB Multiphor apparatus with PAG plates (pH 3.0-8.0; Pharmacia LKB, Lisbon, Portugal). -Lactamase activity was detected by the chromogenic nitrocefin test. Standard enzymes (including CAZ-1/TEM-5, CAZ-6/TEM-24, CAZ-7/TEM-16, TEM-10 and TEM-26) were used as pI markers.
-Lactamase assays
Enzymes were extracted from the transconjugants as described above. Hydrolysis of -lactam antibiotics (ceftazidime, cefotaxime and aztreonam) was monitored spectrophotometrically at 25°C in 0.1 M phosphate buffer, pH 7.0, using a Shimadzu UV-160A spectrophotometer, with each measurement taken at least in duplicate. The computer program Madonna 12 was used to calculate kinetic parameters (K m and V max ) by four methods of calculation (direct linear plot, Lineweaver-Burk, Hanes-Woolf and EadieHofstee).
Plasmid DNA
Plasmid DNA was isolated from K. pneumoniae and transconjugants by alkaline lysis. 13 DNA samples were electrophoresed in 0.7% agarose gels at 12 V/cm for 2 h. Plasmid size was estimated using plasmid molecular weight standards. Restriction enzyme digestion was performed as described by Sambrook et al. 14 with KpnI, PstI, BamHI and EcoRI (IZASA).
DNA amplification by PCR
A 1006 bp fragment of the TEM -lactamase gene carried by the isolates was amplified by PCR from the uncut plasmid DNA of the K. pneumoniae and respective transconjugants. TEM primers A and B 15 (Table I) were used. Amplification conditions were the following: 32 cycles of 94°C for 1 min, 60°C for 1 min and 70°C for 1 min, with a final elongation step of 10 min.
Nucleotide sequence determination
Determination of the nucleotide sequence of the -lactamase gene was performed using the dideoxynucleotide chain termination method.
17 Two additional primers, C and D (Table  I) , were chosen using the program PCRPLAN (PCGene; IntelliGenetics, Geneva, Switzerland), to obtain the complete sequence of both strands of the 1006 bp fragment.
Results
Susceptibility tests
All 138 isolates of K. pneumoniae were resistant to amoxycillin, ceftazidime, aztreonam, gentamicin and netilmicin, but they were susceptible to imipenem, norfloxacin, pefloxacin and nalidixic acid. All had reduced susceptibility to amikacin, cefoxitin, cefuroxime and cefotaxime. All isolates exhibited a degree of resistance to ceftazidime or aztreonam much higher than that to cefotaxime. The presence of clavulanic acid enhanced the antibacterial activities of ceftazidime and aztreonam.
All the isolates had MICs Ͼ 32 mg/L for ceftazidime. However, these isolates had various degrees of susceptibility to aztreonam (MIC ranging from 16 to Ͼ256 mg/L), cefotaxime (MIC range 0.125-3.0 mg/L), cefepime (MIC range 0.38-3.0 mg/L) and cefuroxime (MIC range 1.5-12 mg/L). The MICs of ceftazidime plus clavulanic acid ranged from Ͻ0.125 to 0.75 mg/L, and showed that the -lactamase inhibitor clavulanic acid restored susceptibility to ceftazidime. The MICs for the E. coli transconjugants were identical to those for the parent isolates.
Genomic macrorestriction analysis by PFGE
PFGE of genomic DNA after digestion with XbaI produced an average of 21 fragments ranging in size from less than 36 kb to approximately 700 kb. Among the 138 isolates analysed, 26 different patterns or PFGE types were revealed. These were classified as: profiles I-VIII ( Figure 1 and Table II) , and profile X, which included all other isolates (18) with unique banding patterns. Among isolates demonstrating profiles I and II, one or two variants showed differences of one band. Among the 130 survey isolates there were 18 distinct genotypes. Profile I was identified in 63 isolates and profile II was found in 37 isolates. Profiles III-VIII were identified in 20 isolates. A high level of genetic heterogeneity was found among the remaining 10 isolates from the survey. This same heterogeneity was observed among the isolates obtained from the sporadic cases at the NICU.
Analytical IEF
IEF showed that the isolates had strongly reactive -lactamases of pI 5.6. In addition, these organisms had -lactamases that focused almost identically to the TEM-1 and SHV-1 (pI 5.4 and 7.6, respectively). Some isolates produced one band of pI 6.8. The transconjugants produced only one band of enzyme activity with a pI of 5.6.
Kinetic parameters
The -lactamase with a pI of 5.6 hydrolysed ceftazidime (V max 13.8 ϫ 10 -1 M/min/mg total protein; K m 110.1 M) 
Characterization of plasmids encoding -lactamases
Different plasmid profiles were observed among the K. pneumoniae isolates. In all isolates analysed, the presence of a single large plasmid of about 50 kb was detected. In addition to this large plasmid, plasmids of lower molecular weights were detected only in some isolates (Figure 2 ). In the E. coli transconjugants, acquisition of resistance to -lactam and aminoglycoside antibiotics was correlated with the 50 kb plasmid. Restriction patterns of these plasmids showed small differences for the various enzymes tested (data not shown).
DNA amplification and sequencing
The TEM -lactamase genes from the transconjugants were amplified and sequenced. As they produced ESBLs with a pI of 5.6, which aligned with TEM-10 and TEM-26, they were amplified with TEM primers (Table I) . For all isolates a 1006 bp PCR product was obtained. The deduced amino acid sequence was identical for each isolate analysed, and included a serine at position 164 and a lysine at position 240 (numbering of Ambler et al.
18
), indicating the presence of TEM-10.
Discussion
This study characterized the genomic DNA of K. pneumoniae using PFGE analysis. The isolates originated from a collection of epidemiologically related isolates (surveyed over 1 year) and from sporadic isolates from the NICU. These isolates had similar antimicrobial resistance patterns and plasmid profiles. Among the 138 K. pneumoniae isolates, PFGE revealed that two profiles were predominant. Profile I was the pattern most frequently encountered in all wards, predominating in the internal medicine wards and the paediatric ward. Profile II predominated in the surgical wards. Of the nine isolates from neonates, eight belonged to profile I. The remaining isolate, showing profile II, was from a neonate who was temporarily transferred to another ward where profile II was predominant. In contrast, the eight sporadic isolates from the NICU showed marked restriction fragment length polymorphism variation.
PFGE has been proposed as a method for epidemiological studies, being considered useful in the investigation of the source, transmission and spread of nosocomial infections caused by the methicillin-resistant Staphylococcus aureus, 19 group B streptococci, 20 K. pneumoniae [21] [22] [23] [24] and Salmonella. 25 Plasmid profile analysis has also been proved to be useful for the study of outbreaks of infection with K. pneumoniae. 21, [26] [27] [28] When combined with PFGE it is an effective tool for investigating the epidemiology of ESBLproducing K. pneumoniae isolates. 28 In our study identical plasmids were detected in different isolates, suggesting that propagation of the outbreak prominently involved plasmid spread, although clonal spread of isolates was seen in all individual wards and predominated in the paediatric and 21 reported an outbreak in which a surprisingly high number of genetically unrelated isolates was involved.
614
The present study determined the incidence of ESBL production amongst clinical isolates from a hospital in Lisbon. This is the first report of ESBL TEM-10 identified in K. pneumoniae isolates in a Portuguese hospital. Ferreira et al. 29 carried out a survey in the Hospital de São João, in the north of Portugal, where they identified, by IEF, 14.3% of K. pneumoniae isolates producing ESBLs with pI Ͼ 7.6. The prevalence of TEM-10 in the Hospital de Santa Maria may be related to the increased usage of extendedspectrum cephalosporins in recent years. However, it is difficult to assess whether or not this resistance developed as a direct result of cephalosporin therapy. According to Hibbert-Rogers et al., 30 even after discontinuation of ceftazidime and other cephalosporins, continued colonization of patients by ESBL-producing Klebsiella isolates has been observed. ESBLs are usually encoded by genes within plasmids that are easily transmitted among different members of the Enterobacteriaceae. The accumulation of resistance genes results in isolates that contain multi-resistance plasmids. The emergence of these multiply resistant Klebsiella isolates at the Hospital de Santa Maria has been accompanied by a relatively high stability of plasmids containing the bla TEM-10 gene. This does not seem to be associated with a significant increase in the use of extended-spectrum cephalosporins. The observation of a plasmid-mediated ESBL present in two isolates from the environment shows that these genes may be maintained in the absence of hospital pressures and that ESBL-producing organisms are no longer confined to nosocomial infections. 31 In summary, this study shows that the ESBL TEM-10 present among K. pneumoniae isolates is widely disseminated in different wards, and its persistence could be explained by dissemination of both the multi-resistance plasmids harbouring the bla gene and the isolates themselves.
